Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
R1 RCM Inc. RCM
$16.26
-$0.11 (-0.70%)
На 18:00, 12 мая 2023
+2.52%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
6852256286.00000000
-
week52high
27.07
-
week52low
6.71
-
Revenue
1806400000
-
P/E TTM
-118
-
Beta
0.83944600
-
EPS
-0.16000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 12:00
Описание компании
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Deutsche Bank | Buy | Buy | 29 июн 2022 г. |
| Guggenheim | Neutral | 14 апр 2022 г. | |
| Deutsche Bank | Buy | 09 февр 2022 г. | |
| B of A Securities | Buy | 03 янв 2022 г. | |
| Jefferies | Buy | 02 дек 2021 г. | |
| Keybanc | Overweight | 16 сент 2022 г. | |
| Truist Securities | Buy | 07 сент 2022 г. | |
| Evercore ISI Group | Outperform | 24 окт 2022 г. | |
| Cowen & Co. | Outperform | Outperform | 14 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 09 ноя 2022 г. |
| RBC Capital | Outperform | Outperform | 09 ноя 2022 г. |
| Keybanc | Overweight | Overweight | 09 ноя 2022 г. |
| JP Morgan | Overweight | Overweight | 18 ноя 2022 г. |
| Guggenheim | Buy | Neutral | 07 дек 2022 г. |
| RBC Capital | Outperform | Outperform | 06 дек 2022 г. |
| Morgan Stanley | Equal-Weight | 06 дек 2022 г. | |
| Keybanc | Overweight | Overweight | 05 дек 2022 г. |
| Canaccord Genuity | Buy | 05 янв 2023 г. | |
| Barclays | Overweight | Overweight | 18 янв 2023 г. |
| Truist Securities | Hold | Buy | 02 февр 2023 г. |
| RBC Capital | Outperform | Outperform | 02 февр 2023 г. |
| Keybanc | Overweight | Overweight | 02 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| TERSIGNI ANTHONY R | A | 36636 | 1398 | 03 янв 2023 г. |
| New Mountain Capital, L.L.C. | A | 11075180 | 9454 | 26 окт 2022 г. |
| New Mountain Capital, L.L.C. | A | 124910408 | 46392 | 26 окт 2022 г. |
| TERSIGNI ANTHONY R | A | 35238 | 796 | 03 окт 2022 г. |
| TCP-ASC ACHI Series LLLP | D | 164754055 | 15000000 | 13 сент 2022 г. |
| SPARBY JOHN M. | D | 123772 | 40000 | 19 авг 2022 г. |
| FLANAGAN JOSEPH GERARD | D | 664849 | 200000 | 18 авг 2022 г. |
| FLANAGAN JOSEPH GERARD | D | 864849 | 200000 | 18 авг 2022 г. |
| FLANAGAN JOSEPH GERARD | D | 1064849 | 200000 | 18 авг 2022 г. |
| FLANAGAN JOSEPH GERARD | D | 2792221 | 200000 | 18 авг 2022 г. |
Новостная лента
R1 RCM, Inc. (RCM) Q1 2023 Earnings Call Transcript
Seeking Alpha
07 мая 2023 г. в 14:42
R1 RCM Inc. (NASDAQ:RCM ) Q1 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Sean Dodge - RBC Capital Markets Michael Cherny - Bank of America Stephanie Davis - SVB Securities Jack Wallace - Guggenheim Securities Craig Hettenbach - Morgan Stanley Elizabeth Anderson - Evercore ISI Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Vikram Kesavabhotla - Baird Jeff Garro - Stephens Operator Ladies and gentlemen, thank you for standing by, and welcome to the R1 RCM First Quarter 2023 Earnings Call. I would now like to turn the call over to Atif Rahim, Head of Investor Relations.
R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q1
Zacks Investment Research
04 мая 2023 г. в 09:55
R1 RCM Inc. (RCM) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago.
R1 RCM to Present at Upcoming Investor Conferences
GlobeNewsWire
02 мая 2023 г. в 17:00
MURRAY, Utah, May 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:
R1 RCM to Release First Quarter 2023 Results on May 4
GlobeNewsWire
18 апр 2023 г. в 17:00
MURRAY, Utah, April 18, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2023, before market open on Thursday, May 4, 2023.
R1 RCM: Cloudmed Already Paying Dividends, Look For Double-Digit Growth In FY23
Seeking Alpha
03 мар 2023 г. в 17:00
The Cloudmed integration appears to be already paying dividends for R1 RCM as a growth accelerator. Projections are for 48% YoY adj. EBITDA growth in FY23.